NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » Industry news back to previous page show list
Wuxi Pharma Tech »07/04/2007 [Industry news]
WuXi PharmaTech Sets Up Life Science and Chemistry Award

WuXi PharmaTech, China's leading provider of pharmaceutical outsourcing services is pleased to announce the establishment of the "WuXi PharmaTech Life Science and Chemistry Award"; worth one million RMB. The award will honor individuals and groups who make a significant contribution to the fields of life science and chemistry in China.

 

 

SHANGHAI, China, April 6 /Xinhua-PRNewswire/ -- WuXi PharmaTech, China's leading provider of pharmaceutical outsourcing services is pleased to announce the establishment of the "WuXi PharmaTech Life Science and Chemistry Award"; worth one million RMB. The award will honor individuals and groups who make a significant contribution to the fields of life science and chemistry in China. Recently approved and endorsed by the National Office of Science and Technology Awards, the annual WuXi PharmaTech Life Science and Chemistry Award is designed to recognize and promote China's scientific and technological development. WuXi PharmaTech will reward students or young professionals of Chinese citizenship who make an outstanding achievement in the field of chemistry, biology, or other life science related disciplines. The award will be given annually and the prize winners will be selected by a panel of famous scientists. WuXi PharmaTech is the first and only private research company in China to sponsor such an award. Other institutions this year that have similarly be recognized by the Chinese Government for the establishment of new funds include the "Soong Ching Ling Foundation Pediatric Medicine Award", and the "China Steel Structure Association Science and Technology Award".

As China's leading research-driven pharmaceutical services company, WuXi PharmaTech hires and trains hundreds of young scientists every year. Through cultivating and encouraging the development of these people, the company is able to provide its collaborative partners with the best possible services. Fully committed to its social responsibilities WuXi PharmaTech hopes this prestigious and career-enhancing award can stimulate and celebrate outstanding achievement in life science and chemistry in China.

"The talent of our scientists is at the heart of our business and inseparable from our success," commented Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech. "As a good corporate citizen believing in giving back to society WuXi PharmaTech is very pleased to fund this award to encourage and support students and young professionals in their life science and chemistry research endeavor. Their achievements ultimately will benefit the greater industry and the society," continued Dr. Li. About WuXi PharmaTech Co., Ltd. Founded in 2001, Shanghai-based WuXi PharmaTech is China's leading drug R&D service company. As a research-driven and customer-focused company, WuXi PharmaTech offers global pharmaceutical and biopharmaceutical companies a diverse, value-added, and fully integrated portfolio of outsourcing services ranging from discovery chemistry, and process chemistry to service biology, bioanalytical chemistry, and large scale GMP manufacturing. WuXi PharmaTech assists its global partners in shortening the cycle and lowering the cost of drug discovery and development by providing cost-effective and efficient outsourcing solutions that save our clients both time and money. Currently, our client list consists of 19 of the top 20 pharmaceutical, and 8 of the top 10 biopharmaceutical companies.


AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.